Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | CTSG | P08311 | 1/20 | 0.37 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.37 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9360843 | 0.98 | ZDHHC7 (0.44) | USP2LMNAZDHHC7CA1CA2 | |
| SCHEMBL328949 | 0.98 | ZDHHC7 (0.44) | USP2LMNAZDHHC7CA1CA2 | |
| SCHEMBL381463 | 0.98 | ZDHHC7 (0.44) | USP2LMNAZDHHC7CA1CA2 | |
| SCHEMBL5852520 | 0.98 | ZDHHC7 (0.44) | USP2LMNAZDHHC7CA1CA2 | |
| SCHEMBL373122 | 0.94 | CA2 (0.46) | USP2LMNAZDHHC7CA1CA2 | |
| SCHEMBL8371638 | 0.89 | FAAH (0.44) | USP2LMNABLMMEN1RECQL | |
| SCHEMBL8371635 | 0.89 | FAAH (0.44) | USP2LMNABLMMEN1RECQL | |
| SCHEMBL911189 | 0.86 | CA2 (0.36) | LMNACA1CA2HSD17B10PRSS1 | |
| SCHEMBL28436199 | 0.85 | CYP4F2 (0.37) | — | |
| SCHEMBL165520 | 0.85 | BLM (0.33) | LMNACA1BLMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4306556-A1 | PROTIC IONIC LIQUID BASED ON DIALLYL AMMONIUM CATION AND RELATED MEMBRANE | Toyota Jidosha Kabushiki Kaisha (JP) | 2024-01-17 | — | — | EP | claimed |
| US-12590220-B2 | Thermosetting composition, method for manufacturing molded article using the same, and cured product | IDEMITSU KOSAN CO. , LTD. (JP) | 2026-03-31 | — | — | US | disclosed |
| EP-4306556-A1 | PROTIC IONIC LIQUID BASED ON DIALLYL AMMONIUM CATION AND RELATED MEMBRANE | Toyota Jidosha Kabushiki Kaisha (JP) | 2024-01-17 | — | — | EP | disclosed |
| CN-116724095-A | Adhesive film, optical member including the same, and optical display device including the same | 三星SDI株式会社 | 2023-09-08 | — | — | CN | disclosed |
| US-20210171683-A1 | THERMOSETTING COMPOSITION, METHOD FOR MANUFACTURING MOLDED ARTICLE USING THE SAME, AND CURED PRODUCT | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-06-10 | — | — | US | disclosed |
| EP-2436056-B1 | Electronic device comprising organic crosslinkable dielectrics and method of preparation thereof | BASF SE (DE) | 2016-08-03 | — | — | EP | disclosed |
| US-8853820-B2 | Crosslinkable dielectrics and methods of preparation and use thereof | BASF SE (DE) | 2014-10-07 | — | — | US | disclosed |
| EP-2436056-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2012-04-04 | — | — | EP | disclosed |
| US-20120068314-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | POLYERA CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2010136385-A1 | CROSSLINKABLE DIELECTRICS AND METHODS OF PREPARATION AND USE THEREOF | BASF SE (DE) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12590220-B2 | Thermosetting composition, method for manufacturing molded article using the same, and cured product | SRMS, LSS, JMJD1C | USP2 1787/4885LMNA 1412/4885ZDHHC7 799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.